Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
Scientific Reports|June 21, 2017
Chronic high fat feeding restricts islet mRNA translation initiation independently of ER stress via DNA damage and p53 activationMasayuki Hatanaka, Emily Anderson-Baucum, Alexander Lakhter, et al.
Diabetes Technology & Therapeutics|January 6, 2025
A Glucose Fraction Independent of Insulin Secretion: Implications for Type 1 Diabetes Progression in Autoantibody-Positive CohortsJay M Sosenko, David Cuthbertson, Laura M Jacobsen, et al.
Molecular Metabolism|July 11, 2021
β-Cell pre-mir-21 induces dysfunction and loss of cellular identity by targeting transforming growth factor beta 2 (Tgfb2) and Smad family member 2 (Smad2) mRNAsSara Ibrahim, Macey Johnson, Clarissa Hernandez Stephens, et al.
Molecular Metabolism|July 11, 2022
Extracellular vesicles in β cell biology: Role of lipids in vesicle biogenesis, cargo, and intercellular signalingRebecca S Aguirre, Abhishek Kulkarni, Matthew W Becker, et al.
Diabetes|March 13, 2023
The Chd4 Helicase Regulates Chromatin Accessibility and Gene Expression Critical for β-Cell Function In VivoRebecca K Davidson, Sukrati Kanojia, Wenting Wu, et al.
Diabetes Care|July 8, 2016
Elevations in the Fasting Serum Proinsulin-to-C-Peptide Ratio Precede the Onset of Type 1 DiabetesEmily K Sims, Zunaira Chaudhry, Renecia Watkins, et al.
JCI Insight|August 10, 2018
β Cell dysfunction exists more than 5 years before type 1 diabetes diagnosisCarmella Evans-Molina, Emily K Sims, Linda A DiMeglio, et al.
Diabetologia|November 7, 2024
Beta cell extracellular vesicle PD-L1 as a novel regulator of CD8+ T cell activity and biomarker during the evolution of type 1 diabetesChaitra Rao, Daniel T Cater, Saptarshi Roy, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Beta cell extracellular vesicle PD-L1 as a novel regulator of CD8+ T cell activity and biomarker during the evolution of Type 1 DiabetesChaitra Rao, Daniel T Cater, Saptarshi Roy, et al.
Science Translational Medicine|March 4, 2021
Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individualsEmily K Sims, Brian N Bundy, Kenneth Stier, et al.
Pageof 11